Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics PeerVoice Brain & Behaviour Audio

Visit https://www.peervoice.com/TMJ860 to view the entire programme with slides. After completing “Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics”, participants will be able to: Summarise key findings from the 24-month analysis of the ENVISION trial in patients with acute hepatic porphyria (AHP); Discuss the current practices and unmet needs for the long-term management of AHP; and Describe the impact of these data on clinical practice within the context of treatment paradigms for the long-term management of patients with AHP.